These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31919372)

  • 1. Structure-activity relationship studies of four novel 4-aminopyridine K
    Rodríguez-Rangel S; Bravin AD; Ramos-Torres KM; Brugarolas P; Sánchez-Rodríguez JE
    Sci Rep; 2020 Jan; 10(1):52. PubMed ID: 31919372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine.
    Sun Y; Rodríguez-Rangel S; Zhang LL; Sánchez-Rodríguez JE; Brugarolas P
    Sci Rep; 2024 May; 14(1):11105. PubMed ID: 38750155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of S6 mutations on binding of quinidine and 4-aminopyridine to rat isoform of Kv1.4: common site but different factors in determining blockers' binding affinity.
    Zhang H; Zhu B; Yao JA; Tseng GN
    J Pharmacol Exp Ther; 1998 Oct; 287(1):332-43. PubMed ID: 9765354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heteromultimeric Kv1.2-Kv1.5 channels underlie 4-aminopyridine-sensitive delayed rectifier K(+) current of rabbit vascular myocytes.
    Kerr PM; Clément-Chomienne O; Thorneloe KS; Chen TT; Ishii K; Sontag DP; Walsh MP; Cole WC
    Circ Res; 2001 Nov; 89(11):1038-44. PubMed ID: 11717161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemical Synthesis and Evaluation of 3-[
    Sun Y; Guehl NJ; Zhou YP; Takahashi K; Belov V; Dhaynaut M; Moon SH; El Fakhri G; Normandin MD; Brugarolas P
    ACS Chem Neurosci; 2022 Dec; 13(23):3342-3351. PubMed ID: 36417797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse use dependence of Kv4.2 blockade by 4-aminopyridine.
    Tseng GN; Jiang M; Yao JA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):865-76. PubMed ID: 8930194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular composition of 4-aminopyridine-sensitive voltage-gated K(+) channels of vascular smooth muscle.
    Thorneloe KS; Chen TT; Kerr PM; Grier EF; Horowitz B; Cole WC; Walsh MP
    Circ Res; 2001 Nov; 89(11):1030-7. PubMed ID: 11717160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gating-dependent mechanism of 4-aminopyridine block in two related potassium channels.
    Kirsch GE; Drewe JA
    J Gen Physiol; 1993 Nov; 102(5):797-816. PubMed ID: 8301258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
    Decher N; Pirard B; Bundis F; Peukert S; Baringhaus KH; Busch AE; Steinmeyer K; Sanguinetti MC
    J Biol Chem; 2004 Jan; 279(1):394-400. PubMed ID: 14578345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different state dependencies of 4-aminopyridine binding to rKv1.4 and rKv4.2: role of the cytoplasmic halves of the fifth and sixth transmembrane segments.
    Tseng GN
    J Pharmacol Exp Ther; 1999 Aug; 290(2):569-77. PubMed ID: 10411564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
    Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
    J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of voltage-gated K+ channels in human atrium.
    Bertaso F; Sharpe CC; Hendry BM; James AF
    Basic Res Cardiol; 2002 Nov; 97(6):424-33. PubMed ID: 12395204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical and biophysical characterization of novel potassium channel blocker 3-fluoro-5-methylpyridin-4-amine.
    Sun Y; Rodríguez-Rangel S; Zhang LL; Sánchez-Rodríguez JE; Brugarolas P
    bioRxiv; 2023 Aug; ():. PubMed ID: 37609160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New screening system for selective blockers of voltage-gated K(+) channels using recombinant cell lines dying upon single action potential.
    Fujii M; Hayashi K; Ohya S; Yamamura H; Imaizumi Y
    J Pharmacol Sci; 2013; 123(2):147-58. PubMed ID: 24096832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Model of the Block of Voltage-Gated Potassium Kv4.2 Ionic Currents by 4-Aminopyridine.
    Kehl SJ
    J Pharmacol Exp Ther; 2017 Nov; 363(2):184-195. PubMed ID: 28864468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.
    Lang R; Lee G; Liu W; Tian S; Rafi H; Orias M; Segal AS; Desir GV
    Am J Physiol Renal Physiol; 2000 Jun; 278(6):F1013-21. PubMed ID: 10836990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels.
    Cuypers E; Abdel-Mottaleb Y; Kopljar I; Rainier JD; Raes AL; Snyders DJ; Tytgat J
    Toxicon; 2008 May; 51(6):974-83. PubMed ID: 18313714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemical strategy to scout 1,4-naphthoquinones effect on voltage gated potassium channels.
    Rodríguez-Fernández T; Ugalde-Saldívar VM; González I; Escobar LI; García-Valdés J
    Bioelectrochemistry; 2012 Aug; 86():1-8. PubMed ID: 22265102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of a gating modifier toxin induces intersubunit cooperativity early in the Shaker K channel's activation pathway.
    Sack JT; Aldrich RW
    J Gen Physiol; 2006 Jul; 128(1):119-32. PubMed ID: 16801385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
    Gao YD; Garcia ML
    Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.